Regeneron Pharmaceuticals, Inc.

Bank of New York Mellon Corp REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

764,242

Value ($000)

589,896

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	589,896	0.1%	764,242	12/31/2025
2025 Q3	11/3/2025	377,638	0.1%	671,630	9/30/2025
2025 Q2	8/5/2025	344,728	0.1%	656,624	6/30/2025
2025 Q1	4/29/2025	442,853	0.1%	698,253	3/31/2025
2024 Q4	2/4/2025	490,983	0.1%	689,263	12/31/2024
2024 Q3	11/12/2024	751,717	0.1%	715,076	9/30/2024
2024 Q2	7/25/2024	908,344	0.2%	864,242	6/30/2024
2024 Q1	4/25/2024	853,290	0.2%	886,544	3/31/2024
2023 Q4	1/29/2024	833,124	0.2%	948,575	12/31/2023
2023 Q3	10/24/2023	796,142	0.2%	967,414	9/30/2023
2023 Q2	8/3/2023	693,210	0.1%	964,748	6/30/2023
2023 Q1	5/9/2023	816,714	0.2%	993,968	3/31/2023
2022 Q4	2/14/2023	710,286	0.2%	984,472	12/31/2022
2022 Q3	11/14/2022	704,526	0.2%	1,022,724	9/30/2022
2022 Q2	8/15/2022	566,219	0.1%	957,857	6/30/2022
2022 Q1	5/11/2022	640,492	0.1%	917,058	3/31/2022
2021 Q4	2/11/2022	558,280	0.1%	884,022	12/31/2021
2021 Q3	11/18/2021	533,052	0.1%	880,815	9/30/2021
2021 Q2	8/11/2021	479,571	0.1%	858,616	6/30/2021
2021 Q1	5/13/2021	400,295	0.1%	846,038	3/31/2021
2020 Q4	2/9/2021	400,141	0.1%	828,264	12/31/2020
2020 Q3	11/12/2020	459,089	0.1%	820,126	9/30/2020
2020 Q2	8/12/2020	482,175	0.1%	773,151	6/30/2020
2020 Q1	5/6/2020	299,108	0.1%	612,562	3/31/2020
2019 Q4	2/14/2020	225,542	0.1%	600,673	12/31/2019
2014 Q1	5/14/2014	304,265	0.1%	1,013,268	3/31/2014
2013 Q4	2/12/2014	331,092	0.1%	1,202,919	12/31/2013